Abstract
Guest–host interaction of prednisone (PN) with cyclodextrins (CDs) have been investigated using phase solubility diagrams (PSD), differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), scanning electron microscopy (SEM) and molecular mechanical modeling (MM). Estimates of the complex formation constant (K 11) show that the tendency of PN to complex with CDs follows the order: β-CD>γ-CD>HP-β-CD>α-CD. At the same pH of 7.0, β-CD forms soluble 1:1 and insoluble 1:2 PN/CD complexes (BS-type PSDs). The thermodynamic functions for 1:1 PN/β-CD estimated at pH = 7.0 (ΔG o11 =−20.8 kJ⋅mol−1) show that complexation is driven by enthalpy (−30.7 kJ⋅mol−1) but retarded by entropy (ΔS o11 =−33.1 J⋅mol−1⋅K−1) changes. The MM modeling study indicates the formation of different isomeric 1:1 complexes with CDs. PSD, DSC, XRPD, SEM and MM studies established the formation of inclusion complexes in solution and the solid state.
Similar content being viewed by others
References
Szejtli, J.: Cyclodextrin Technology, pp. 8–72. Kluwer, Dordrecht (1989)
Sadlej-Sosnowska, N.: Influence of the structure of steroid hormones on their association with cyclodextrin: A high-performance liquid chromatography study. J. Inclusion Phenom. Molec. Recog. Chem. 27, 31–40 (1997)
Cserháti, T., Forgács, E.: Inclusion complex formation of steroidal drugs with hydroxypropyl-β-cyclodextrin studied by charge-transfer chromatography. J. Pharm. Biomed. Anal. 18, 179–185 (1998)
Flood, K.G., Reynolds, E.R., Snow, N.H.: Characterization of inclusion complexes of betamethasone-related steroids with cyclodextrin using high-performance liquid chromatography. J. Chrom. A 903, 49–65 (2000)
Flood, K.G., Reynolds, E.R., Snow, N.H.: Determination of apparent association constants of steroid-cyclodextrin inclusion complexes using a modification of the Hummel-Dreyer method. J. Chrom. A 913, 261–268 (2001)
Forgo, P., Göndös, G.: A study of β-cyclodextrin inclusion complexes with progesterone and hydrocortisone using rotating frame overhauser spectroscopy. Monatshefte für Chemie 133, 101–106 (2002)
Weinzinger, P., Weiss-Greiler, P., Snor, W., Viernstein, H., Wolschann, P.: Molecular dynamics simulations and quantum chemical calculations on β-cyclodextrin–spironolactone complex. J. Inclusion Phenom. Macrocycl. Chem. 57, 29–33 (2007)
Chun, I.K., Yun, D.S.: Inclusion complexation of hydrocortisone butyrate with cyclodextrins and dimethyl-β-cyclodextrin in aqueous solution and in solid state. Int. J. Pharm. 31, 91–103 (1993)
Vianna, R.F.L., Bentley, M.V.L.B., Ribeiro, G., Carvalho, F.S., Neto, A.F., de Oliveira, D.C.R., Collett, J.H.: Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int. J. Pharm. 167, 205–213 (1998)
de Hassonville, S.H., Perly, B., Piel, G., Hees, T.V., Barillaro, V., Bertholet, P., Delattre, L., Evrard, B.: Inclusion complexes of cyproterone acetate with cyclodextrin in aqueous solution. J. Incl. Phenom. Macrocycl. Chem. 44, 289–292 (2002)
Lula, I., Gomes, M.F., Piló-Veloso, D., de Noronha, A.L.O., Duarte, H.A., Santos, R.A.S., Sinisterra, R.D.: Spironolactone and its complexes with β-cyclodextrin: Modern NMR characterization and structural DFTB-SCC calculations. J. Incl. Phenom. Macrocycl. Chem. 56, 293–302 (2006)
Al-Sou’od, K.A.: Investigation of the hydrocortisone-β-cyclodextrin complex by phase solubility method: Theoretical and practical considerations. J. Solution Chem. 37, 119–133 (2008)
Anderson, F.M., Bundgaard, H.: The influence of cyclodextrin complexation on the stability of betamethasone-17-valerate. Int. J. Pharm. 20, 155–162 (1984)
Arimori, K., Sakai, A., Otagiri, M., Uekama, K.: Improvement in biopharmaceutics of prednisolone by β- and γ-cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 1, 387–394 (1984)
Elshaboury, M.H.: Physical properties and dissolution profiles of tablets directly compressed with β-cyclodextrin. Int. J. Pharm. 63, 95–100 (1990)
Stella, V.J., Lee, H.K., Thompson, D.O.: The effect of SBE4–β-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: Comparison to a co-solvent solution and a water-soluble prodrug. Int. J. Pharm. 120, 197–204 (1995)
Okimoto, K., Miyake, M., Ohnishi, N., Rajewski, R.A., Stella, V.J., Irie, T., Uekama, K.: Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m–β-CD. Pharm. Res. 15, 1562–1568 (1998)
Filipović-Grčić, J., Voinovich, D., Moneghini, M., Bećirević-Laćan, M., Magarotto, L., Jalšenjak, I.: Chitosan microsphere with hydrocortisone and hydrocortisone-hydroxypropy-β-cyclodextrin inclusion complex. Eur. J. Pharm. Sci. 9, 373–379 (2000)
Zoppetti, G., Puppini, N., Pizzutti, M., Fini, A., Giovani, T., Comini, S.: Water soluble progesterone–hydroxypropyl-β-cyclodextrin complex for injectable formulations. J. Incl. Phenom. Macrocycl. Chem. 57, 283–288 (2007)
AHFS drug information. Prednisone. www.ashp.org/mngrphs/ahfs/a382796.htm
Prednisone USP monograph. In United States Pharmacopoeia (USP); 31th edn. pp. 3068–3069, USP Convention. INC: Maryland (2008)
Ferry, J.J., Horvath, A.M., Bekersky, I., Heath, E.C., Ryan, C.F., Colburn, W.A.: Relative and absolute bioavailability of prednisone and prednisolone after separate oral intravenous doses. J. Clin. Pharmacol. 28, 81–87 (1988)
Higuchi, T., Connors, K.A.: Phase solubility techniques. Adv. Anal. Chem. Instr. 4, 117–212 (1965)
Zughul, M.B., Badwan, A.A.: SL 2 type phase solubility diagrams, complex formation and chemical speciation of soluble species. J. Incl. Phenom. Macrocycl. Chem. 31, 243–264 (1998)
Al-Sou’od, K.A., Zughul, M.B., Badwan, A.A.: Experimental and molecular mechanical studies of complexation of some 2H- and 3H-indole derivative with aqueous β-cyclodextrin. J. Solution Chem. 35, 1377–1388 (2006)
Al-Sou’od, K.A.: Investigation of the hydrocortisone–β-cyclodextrin complex by phase solubility method: Some theoretical and practical considerations. J. Solution Chem. 37, 119–133 (2007)
Linder, K., Saenger, W.: Crystal and molecular structure of cyclohepta-amylose dodecahydrate. Carbohydr. Res. 99, 103–115 (1982)
Saenger, W., Jacob, J., Gessler, K., Steiner, T., Hoffman, D., Sanbe, H., Koizumi, K., Smith, S.M., Takaha, T.: Structures of the common cyclodextrins and their large analogues-beyond the doughnut. Chem. Rev. 98, 1787–1802 (1998)
Harata, K.: The structure of the cyclodextrin complex. XX. Crystal-structure of uncomplexed hydrate γ-cyclodextrin. Bull. Chem. Jpn. 60, 2763–2767 (1987)
Taraszewska, J., Migut, K., Kozbiat, M.: Complexation of flutamide by native and modified cyclodextrins. J. Phys. Org. Chem. 16, 121–126 (2003)
Nalluri, B.N., Chowdary, K.R., Murthy, K.R., Hayman, A.R., Becket, G.: Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech. 4 Article 2 (2003). http://www.aapspharmscitech.org
Yoshida, A., Yamamoto, M., Irie, T., Hirayama, F., Uekama, K.: Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. Chem. Pharm. Bull. 37, 1059–1063 (1989)
Ribeiro, L., Veiga, F.: Complexation of vinpocetine with cyclodextrins in the presence or absence of polymers: Binary and ternary complexes preparation and characterization. J. Incl. Phenom. Macrocycl. Chem. 44, 251–256 (2002)
Yannis, L.L.: Complexation of haloperidol with a water-soluble β-cyclodextrin polymer: Characterization of the inclusion complex in solid state and in aqueous solution. Pharm. Sci. 1, 509–512 (1995)
Yannis, L.L., Varka, V., Gregoriadis, G.: Novel non-acidic formulations of haloperidol complexed with β-cyclodextrin derivatives. J. Pharm. Biomed. Anal. 16, 263–268 (1997)
Wensheng, C., Xuexia, Y., Xueguang, S., Zhongxiao, P.: Bimodal complexation of steroids with cyclodextrin by a flexible docking algorithm. J. Incl. Phenom. Macrocycl. Chem. 51, 41–51 (2005)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghuzlaan, A., Al Omari, M.M. & Al-Sou’od, K.A. Prednisone/Cyclodextrin Inclusion Complexation: Phase Solubility, Thermodynamic, Physicochemical and Computational Analysis. J Solution Chem 38, 83–94 (2009). https://doi.org/10.1007/s10953-008-9349-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10953-008-9349-0